chr4-5793685-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_153717.3(EVC):​c.1854C>T​(p.Gly618Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.327 in 1,550,636 control chromosomes in the GnomAD database, including 87,731 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G618G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.27 ( 6782 hom., cov: 32)
Exomes 𝑓: 0.33 ( 80949 hom. )

Consequence

EVC
NM_153717.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.80

Publications

21 publications found
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 4-5793685-C-T is Benign according to our data. Variant chr4-5793685-C-T is described in ClinVar as Benign. ClinVar VariationId is 262769.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.8 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.517 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_153717.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC
NM_153717.3
MANE Select
c.1854C>Tp.Gly618Gly
synonymous
Exon 13 of 21NP_714928.1
EVC
NM_001306090.2
c.1854C>Tp.Gly618Gly
synonymous
Exon 13 of 21NP_001293019.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC
ENST00000264956.11
TSL:1 MANE Select
c.1854C>Tp.Gly618Gly
synonymous
Exon 13 of 21ENSP00000264956.6
EVC
ENST00000506240.1
TSL:3
n.172C>T
non_coding_transcript_exon
Exon 1 of 2
EVC
ENST00000515113.1
TSL:5
n.78C>T
non_coding_transcript_exon
Exon 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41578
AN:
151892
Hom.:
6776
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.310
Gnomad EAS
AF:
0.516
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.284
GnomAD2 exomes
AF:
0.355
AC:
55868
AN:
157544
AF XY:
0.369
show subpopulations
Gnomad AFR exome
AF:
0.0953
Gnomad AMR exome
AF:
0.345
Gnomad ASJ exome
AF:
0.314
Gnomad EAS exome
AF:
0.514
Gnomad FIN exome
AF:
0.319
Gnomad NFE exome
AF:
0.319
Gnomad OTH exome
AF:
0.337
GnomAD4 exome
AF:
0.333
AC:
465360
AN:
1398626
Hom.:
80949
Cov.:
37
AF XY:
0.339
AC XY:
233910
AN XY:
689968
show subpopulations
African (AFR)
AF:
0.0979
AC:
3108
AN:
31738
American (AMR)
AF:
0.341
AC:
12223
AN:
35866
Ashkenazi Jewish (ASJ)
AF:
0.304
AC:
7660
AN:
25184
East Asian (EAS)
AF:
0.504
AC:
18100
AN:
35884
South Asian (SAS)
AF:
0.520
AC:
41229
AN:
79214
European-Finnish (FIN)
AF:
0.319
AC:
15743
AN:
49354
Middle Eastern (MID)
AF:
0.333
AC:
1448
AN:
4354
European-Non Finnish (NFE)
AF:
0.321
AC:
346699
AN:
1079140
Other (OTH)
AF:
0.331
AC:
19150
AN:
57892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
17319
34638
51958
69277
86596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11516
23032
34548
46064
57580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41603
AN:
152010
Hom.:
6782
Cov.:
32
AF XY:
0.283
AC XY:
21037
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.103
AC:
4265
AN:
41508
American (AMR)
AF:
0.318
AC:
4863
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
1075
AN:
3472
East Asian (EAS)
AF:
0.518
AC:
2657
AN:
5134
South Asian (SAS)
AF:
0.534
AC:
2565
AN:
4804
European-Finnish (FIN)
AF:
0.319
AC:
3366
AN:
10546
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.321
AC:
21812
AN:
67958
Other (OTH)
AF:
0.282
AC:
596
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1432
2865
4297
5730
7162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.224
Hom.:
1410
Bravo
AF:
0.265
Asia WGS
AF:
0.481
AC:
1671
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Ellis-van Creveld syndrome Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Curry-Hall syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
1.7
DANN
Benign
0.80
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11737221; hg19: chr4-5795412; COSMIC: COSV53832761; API